--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 14.700
- -0.068-0.46%
Close Nov 22 16:00 ET
- 14.700
- 0.0000.00%
Post 16:00 ET
5.17BMarket Cap161.54P/E (TTM)
15.060High14.610Low34.17KVolume15.000Open14.768Pre Close507.65KTurnover0.20%Turnover Ratio1470.00P/E (Static)351.68MShares19.99052wk High19.65P/B249.90MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM3.05%Amplitude14.440Historical Low14.858Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data